MYNZ

Mainz Biomed N.V. · NASDAQ

Sector Health Technology
Industry Biotechnology
Website mainzbiomed.com
Employees(FY) 58
ISIN NL0015000LC2

Performance

+51.02%

+46.05%

-34.71%

-51.39%

+54.17%

YTD

-82.84%

Profile

Mainz Biomed N.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics. It offers ColoAlert, a colorectal cancer screening stool-based deoxyribonucleic acid test; and PancAlert, a product candidate for a pancreatic cancer screening test. The company has a research collaboration with Microba Life Sciences to discover and develop novel therapeutics for major diseases. The company was founded in 2008 and is based in Mainz, Germany.

Advanced Technical Analysis

Technical Analysis of MYNZ 2025-01-31

The stock indicators reflect a generally bullish sentiment, with the Moving Average Score at 63 indicating strong upward momentum, while the Oscillators Score of 56 and Technical Score of 60 suggest a neutral to positive outlook. Overall, these scores imply a favorable market environment, signaling potential for continued price appreciation.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of MYNZ

Stock Rank

Recent News & Updates

2025-01-26 19:01
Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements(Globenewswire)
2025-01-20 19:01
Mainz Biomed Initiates U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over Large Patient Population(Globenewswire)
2024-12-19 21:31
Mainz Biomed partners with Quest for colorectal cancer screening test(Yahoo Finance)
2024-12-18 19:01
Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test(Globenewswire)
2024-12-16 04:00
Mainz Biomed Announces Closing of $8.0 Million Follow-On Offering(Globenewswire)
2024-12-12 07:00
Mainz Biomed Announces Pricing of $8.0 Million Follow-On Offering Priced at-the-Market Under Nasdaq Rules(Globenewswire)
2024-11-28 19:45
Mainz Biomed Announces Stock Split(Globenewswire)
2024-11-13 06:23
The Oncology Bet Is Already Paying Off For Pfizer(Yahoo Finance)
2024-11-11 20:00
Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets(Globenewswire)
2024-10-21 20:10
Mainz Biomed restructured operations, implemented cost reductions(Yahoo Finance)
2024-10-20 20:01
Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update(Globenewswire)
2024-10-10 05:37
Mainz Biomed Secures Additional $1.5M Funding(Yahoo Finance)
2024-10-07 20:01
Mainz Biomed Reports Increased Demand for Enhanced ColoAlert, Existing Partners to Transition to New Version(Yahoo Finance)
2024-10-01 02:11
The Covid Era Tech Promises To Reinvent Cancer Treatment(Yahoo Finance)
2024-09-30 20:01
Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025(Globenewswire)
2024-09-19 22:48
Pfizer Advances On Its Cancer Journey(Yahoo Finance)
2024-09-17 20:01
Mainz Biomed Announces Petra Smeltzer Starke to Join Company as Brand Ambassador(Globenewswire)
2024-09-03 16:01
Mainz Biomed Partners with Liquid Biosciences to Leverage the Power of Artificial Intelligence for the Expansion and Optimization of Biomarker Selection for PancAlert(Yahoo Finance)
2024-07-30 00:09
Pfizer Records First Sales Growth In Its Post-Covid Era And It Owes It To Cancer(Yahoo Finance)
2024-07-24 20:01
Mainz Biomed Launches Enhanced ColoAlert with Cutting-Edge Features to Optimize Screening Efficiency and User Convenience(Yahoo Finance)
2024-07-19 00:38
Mainz BioMed Seeks FDA Breakthrough Device Designation for Advanced Colorectal Cancer Test(Newsdirect)
2024-07-09 16:12
Mainz Biomed seeks FDA breakthrough device status for colorectal cancer test(Yahoo Finance)
2024-07-08 19:39
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday(Investorplace)
2024-07-08 15:01
Mainz Biomed Announces Submission for FDA Breakthrough Device Designation for its Next Generation CRC Screening Test(Globenewswire)
2024-07-02 01:38
mRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment(Yahoo Finance)
2024-07-01 20:01
Mainz Biomed Provides Half Year 2024 Corporate Update(Globenewswire)
2024-06-04 01:45
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon(Yahoo Finance)
2024-06-02 20:01
Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024(Globenewswire)
2024-05-31 05:01
Mainz Biomed Reports Results of 2024 Annual General Meeting(Globenewswire)
2024-05-28 19:39
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday(Investorplace)

Page 1 of 5

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.